Skip to content

Restricted fluid resuscitation among pregnant women with hemorrhagic shock : a randomised clinical study

Restricted fluid resuscitation among pregnant women with hemorrhagic shock : a randomised clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001275
Enrollment
Unknown
Registered
2011-04-08
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhagic shock in pregnant women

Interventions

PLS:Second stage: restricted isotonic saline + colloid fluid administrated intravenously in pre-hospital resuscitation to maintain the MAP in optimal range.
PLH:Second stage: restricted isotonic saline + hypertonic solution chloride hydroxyethyl starch 40 administrated intravenously in pre-hospital resuscitation to maintain the MAP in optimal range
PLS60:First stage: restricted fluid administration in pre-hospital resuscitation to maintain MAP within 60-70 mmHg
PNL:First stage: restricted fluid administration in pre-hospital resuscitation to maintain MAP over 70 mmHg
PLS50:First stage: restricted fluid administration in pre-hospital resuscitation to maintain MAP within 50-60 mmHg

Sponsors

Southern Medical University nanfang hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-40 yrs; 2. Patients with mild to moderate hemorrhagic shock followed by rupture of ectopic pregnancy or delivery (first systolic pressure<90 mmHg), and with active bleeding before stanching bleeding; 3. Hemorrhagic shock is due to explicit obstetric cause; 4. Patients voluntarily signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with complication of pregnancy; 2. Patients with history of chronic disease; 3. The bleeding is due to coagulation disorder or amniotic fluid embolism; 4. The first mean arterial pressure<50mmHg.

Design outcomes

Primary

MeasureTime frame
Blood loss volume;Mortality;Transfusion volume;

Secondary

MeasureTime frame
Wound healing;Incidence of hysterectomy, MODS or ARF;Total expense of hospitalization;Total in-hospital day;

Countries

China

Contacts

Public ContactYanhong Yu
yuyh@fimmu.com+86 13503080093

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026